Publication Name	World Journal of Transplantation
Manuscript ID	26863
Country	United States

Received	2016-04-28 17:28
Peer-Review Started	2016-04-28 21:02
To Make the First Decision	2016-07-04 15:38
Return for Revision	2016-07-05 20:02
Revised	2016-08-27 19:12
Second Decision	2016-09-12 10:03
Accepted by Journal Editor-in-Chief	2016-09-12 14:58
Accepted by Company Editor-in-Chief	2016-09-22 14:08
Articles in Press	2016-09-22 14:08
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-12-05 14:28
Publish the Manuscript Online	2016-12-14 14:32

ISSN	2220-3230 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Retrospective Study
Article Title	Tacrolimus confers lower acute rejection rates and better renal allograft survival compared to cyclosporine
Manuscript Source	Invited Manuscript
All Author List	Mahmoud Kamel, Manish Kadian, Titte Srinivas, David Taber and Maria Aurora Posadas Salas
Funding Agency and Grant Number
Corresponding Author	Maria Aurora Posadas Salas, MD, Department of Medicine, Medical University of South Carolina, 96 Jonathan Lucas St., Charleston, SC 29425, United States. posadas@musc.edu
Key Words	Tacrolimus; Cyclosporine; Renal allograft survival
Core Tip	Tacrolimus (FK) has surpassed cyclosporine (CYA) as the calcineurin inhibitor (CNI) of choice for the vast majority of kidney transplant (KTX) programs. Yet, CYA continues to be an important alternative for patients intolerant to FK. FK is associated with significantly lower rate of acute rejection and better graft survival compared to CYA. Individualizing immunosuppression through risk-stratified CNI choice may lead to improved outcomes across all spectra of KTX patients.
Publish Date	2016-12-14 14:32
Citation	Kamel M, Kadian M, Srinivas T, Taber D, Posadas Salas MA. Tacrolimus confers lower acute rejection rates and better renal allograft survival compared to cyclosporine. World J Transplant 2016; 6(4): 697-702
URL	http://www.wjgnet.com/2220-3230/full/v6/i4/697.htm
DOI	http://dx.doi.org/10.5500/wjt.v6.i4.697

Full Article (PDF)	WJT-6-697.pdf
Full Article (Word)	WJT-6-697.doc
Manuscript File	26863-Review.docx
Answering Reviewers	26863-Answering reviewers.pdf
Audio Core Tip	26863-Audio core tip.mp3
Biostatistics Review Certificate	26863-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	26863-Conflict of interest statement.pdf
Copyright License Agreement	26863-Copyright assignment.pdf
Institutional Review Board Approval Form or Document	26863-Institutional review board statement.pdf
Peer-review Report	26863-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	26863-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	26863-Scientific misconduct check.pdf
Scientific Editor Work List	26863-Scientific editor work list.pdf